The GlaxoSmithKline cervical cancer candidate vaccine, CERVARIX(R), demonstrated 100 percent efficacy in preventing precancerous lesions due to cancer-causing human papillomavirus types 16 and 18 for up to 5.5 years in an extended follow-up trial, according to data presented at the American Association for Cancer Research.
Researchers from University of Berne in Switzerland revealed that dietary supplement chondroitin not helpful at easing the hip and knee pain of arthritis.
Results of two studies funded by Project A.L.S. and appearing in today’s advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig’s disease.
A consortium of Canadian and American researchers report in Nature Genetics the results from a search of the entire human genome for genetic risk factors leading to the development of Crohn’s disease.
Regular aspirin use was associated with lower cancer incidence and cancer mortality, but non-aspirin non-steroidal anti-inflammatory drug (NSAID) use was not, according to one of the largest studies ever conducted to look at the impact of these agents on overall cancer risk.
Just a few months after their landmark article in Science magazine reporting the discovery of strong links between variations in a gene that codes for a cellular receptor involved in controlling inflammation and Crohn’s disease, a consortium of U.S. and Canadian researchers is reporting in today’s online issue of Nature Genetics that they have discovered several more genetic variations that are strongly linked to an increased risk for the disease.
Breastfeeding can offset the increased risk of invasive breast cancer for women who had their first full-term pregnancy after the age of 25, a study led by researchers at the University of Southern California (USC) suggests.
Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo, according to researchers from the UCLA Medical Center at the 2007 Annual Meeting of the American Association for Cancer Research.
The EU Osteoporosis Consultation Panel, supported by the International Osteoporosis Foundation, is meeting on April 18 in Brussels, Belgium, to begin preparations for a second EU-wide audit on the status of osteoporosis in Europe.
Gay and bisexual men may be at far higher risk for eating disorders than heterosexual men, according to a study conducted at Columbia University’s Mailman School of Public Health.